Resultado de búsqueda
1 de abr. de 2022 · Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients.
- S4.1-2
Valvular heart disease: ACC/AHA: 2017 S1.5-16 Assessment of...
- 2010 Accf/Aha Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Markers reflective of autonomic nervous system function can...
- Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies
Definition of Dilated Cardiomyopathy. The term dilated...
- 2011 Accf/Aha Guideline for Coronary Artery Bypass Graft Surgery
The American College of Cardiology Foundation (ACCF) and the...
- Correction To
In the article by Heidenreich et al, “2022 AHA/ACC/HFSA...
- Richard W. Nesto
The American Heart Association (AHA) and the American...
- Post–Cardiac Arrest Care
Systems of Care for Improving Post–Cardiac Arrest Outcomes....
- S4.1-2
1 de abr. de 2022 · The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients’ interests.
1 de abr. de 2022 · Learn about the 2022 guideline for heart failure management by the American Heart Association.
The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients' interests.
1 de abr. de 2022 · The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients’ interests.
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure – DOI: 10.1016/j.cardfail.2022.02.010. Value Statements for Recommendations (2/2) 6) New Recommendations for Amyloid Heart Disease. Diagnosis of Cardiac Amyloidosis. Diagnostic and Treatment of Transthyretin Cardiac. Amyloidosis Algorithm. Heidenreich PA, et al. J Card Fail 2022.
2 de abr. de 2022 · Guideline-directed medical therapy (GDMT) for heart failure (HF) with reduced ejection fraction (HFrEF) now includes 4 medication classes which include sodium-glucose
